Core Viewpoint - Taihe Co., Ltd. officially listed on the Shenzhen Stock Exchange's Growth Enterprise Market on April 11, marking a significant milestone in its development journey [1]. Group 1: Company Overview - Taihe Co., Ltd. was established in 2004, focusing on the research, production, and sales of pesticide products and functional chemicals, with exports covering major markets in South America, North America, Southeast Asia, and Europe [3]. - The company’s three core products, including Bacillus thuringiensis, Pyraclostrobin, and 2,4-D, are industry leaders, with production scale and comprehensive technology at the forefront of the industry [3]. - Taihe has established globally leading production bases in Jiangsu and Jiangxi, creating a product system that promotes the synergistic development of pesticides and functional chemicals [3]. Group 2: Strategic Partnerships and Development - Zhang Zhenghua, Chairman of Best Consulting, attended Taihe's listing celebration and witnessed this significant moment, highlighting the fruitful collaboration between the two parties [5]. - Best Consulting has been a strategic partner of Taihe, working closely on management transformation projects to promote comprehensive development [5]. - To ensure efficient project advancement, Taihe established a management transformation project team called the L.E.A.D. project group, which focuses on strategic planning, organizational collaboration, and talent cultivation [5].

Core Points - C Taihe (301665) experienced a significant increase of 289.97% on its first trading day, with a turnover rate of 82.87% and a transaction volume of 1.22 billion yuan [1] - The stock attracted a net inflow of 260 million yuan from major funds on its debut, with large orders contributing 94.77 million yuan and 165 million yuan respectively [2] - The financing buy-in amount on the first day was 32.69 million yuan, accounting for 2.68% of the total trading volume, while the latest financing balance stood at 29.46 million yuan, representing 2.05% of the circulating market value [1][2] Company Overview - The company primarily engages in the research, production, and sales of pesticide products and functional chemicals [2] - On the first trading day, the top five trading departments on the leaderboard had a combined transaction volume of 126 million yuan, with a net buying amount of 59.33 million yuan [2] Financing and Margin Trading - The first-day financing balance for C Taihe was 29.46 million yuan, which is 2.05% of its circulating market value, while there was no margin trading balance reported [1][2] - Recent new stocks have shown varying first-day financing balances and price changes, indicating a trend in investor interest and market dynamics [2][3]

Core Insights - Taihe Chemical Co., Ltd. officially listed on the Shenzhen Stock Exchange's ChiNext board on April 11, with an initial offering price of 10.27 CNY per share, closing at 40.05 CNY, marking a 289.97% increase [1] - The company specializes in the research, production, and sales of pesticide products and functional chemicals, holding a leading position in key products such as Bacillus thuringiensis, Pyraclostrobin, and 2,4-D, with Bacillus thuringiensis accounting for over 50% of global production capacity [1][2] - The sales volume of the three core products for the first half of 2024 saw significant year-on-year increases of approximately 42% for 2,4-D, 131% for Bacillus thuringiensis, and 44% for Pyraclostrobin, with the sales rates for Bacillus thuringiensis and Pyraclostrobin exceeding 90% for three consecutive years [1] Financial Performance - The company has demonstrated strong revenue growth from 2021 to 2024, with reported revenues of 3.579 billion CNY in 2021, 5.099 billion CNY in 2022, 3.868 billion CNY in 2023, and an audited revenue of 4.214 billion CNY in 2024 [2] - The expansion into functional chemicals, including high-value products like tetrachloropropene, has broadened the company's application range and facilitated cross-industry breakthroughs [2]

中国经济网北京4月11日讯今日，南通泰禾化工股份有限公司(股票简称：泰禾股份（301665），股票代码：301665.SZ)在深 交所创业板上市。该股开盘报45.00元，截至收盘报40.05元，涨幅289.97%，成交额12.21亿元，振幅55.89%，换手率 82.87%，总市值180.22亿元。 泰禾股份主要从事农药产品以及功能化学品的研发、生产和销售。公司在百菌清、嘧菌酯、2,4-D等三大核心产品上拥有行 业领导地位，生产规模及综合技术方面居于行业领先水平。 公司控股股东为泰禾集团有限公司，公司的实际控制人为田晓宏。本次发行前，控股股东泰禾集团持有公司85.39%股权， 田晓宏间接持有泰禾集团100%的股权。 泰禾股份本次公开发行股票数量为4,500.0000万股，占发行后总股本的比例为10.00%，本次发行股份均为新股，公司股东不 进行公开发售股份，发行价格为10.27元/股。泰禾股份本次的保荐人(主承销商)为光大证券股份有限公司，保荐代表人杜攀 明、刘铁波。 泰禾股份本次发行募集资金总额为46,215.00万元，扣除发行费用后的实际募集资金净额为38,977.28万元。泰禾股份4月7日 披露的招股书 ...

2025年4月11日，创新型农化优质企业南通泰禾化工股份有限公司（证券简称"泰禾股份"，证券代 码"301665"）在深圳证券交易所创业板挂牌，完成A股首次公开发行股票。 泰禾股份表示，本次发行上市后，公司将利用资本市场平台优势，进一步完善产业链、丰富产品组合、加强 创制产品的持续研发，以提升整体市场竞争优势。同时，公司将以上市为契机，扩大品牌影响力和知名度， 推动主营业务的高质量发展和规范运作。 多方面处于行业先进水平 粮食是人类赖以生存的基础物资，粮食问题始终伴随着人类社会的发展。根据联合国《世界人口展望：2019 年修订》的数据及预测，全球人口预计将在2030年达到85亿，2050年达到97亿，2100年达到109亿。与此同 时，近年来，全球可耕地面积却一直维持在14亿公顷左右，未来全球人口不断增加与可耕地面积有限的矛盾 将日益激化。 为满足不断增长的粮食需求，使用农药提升单位面积的产量，成为满足粮食需求的重要解决途径，使得农药 需求伴随农业的发展持续增长。同时，农作物种植结构的变化也促进了农药需求的增长。 文/李彬 公开资料显示，泰禾股份成立于2004年4月，主要从事农药产品以及功能化学品的研发、生产 ...

Group 1 - Nantong Taihe Chemical Co., Ltd. officially listed on the ChiNext board on April 11, raising 462 million yuan by issuing 45 million shares at a price of 10.27 yuan per share, marking the first listing in Nantong for 2025 [1] - Taihe is a leading player in the domestic pesticide industry, focusing on the research and production of three core products: Bacillus thuringiensis, pyraclostrobin, and 2,4-D, with a globally leading production base established in the Youkou Chemical Industrial Park [1] - The company has maintained a production capacity utilization rate exceeding 100% for three consecutive years for its three core products, with a market presence in multiple countries and regions, establishing long-term strategic partnerships with multinational companies such as Syngenta, Dow, and UPL [1] Group 2 - Taihe has developed a product matrix covering 229 overseas self-registration certificates, with its self-created product, cyhalofop-butyl, receiving a special export pesticide registration certificate from the Ministry of Agriculture and Rural Affairs in July 2024, enabling the company to expand its business scope and industry position [2] - The company holds a total of 363 patents, including 73 overseas invention patents and 148 domestic invention patents, with R&D investment consistently above 3%, forming an innovation system centered on ammonia oxidation, chlorination, and hydrogenation reaction technologies [2] - The listing of Taihe has increased the total number of listed companies in Nantong to over 59, creating a "double 59" pattern with the number of companies listed on the New Third Board, reflecting Nantong's proactive approach to capital market reforms and innovation-driven development [2]

Core Insights - The agricultural chemical industry is undergoing a significant transformation from "quantity" to "quality" driven by global food security demands and modernization processes [2] - Taihe Co., Ltd. is positioned as a leader in the domestic market and is showcasing China's manufacturing capabilities on the international stage [2] - The company is transitioning from imitation to innovation, emphasizing its strategic management and operational execution to build a competitive moat [2] Industry Overview - The global agricultural pesticide market reached $74.8 billion in 2023, with a compound annual growth rate (CAGR) of 5.74% over the past five years [9] - The demand for pesticides is driven by global population growth and limited arable land, with herbicides, fungicides, and insecticides accounting for 47.2%, 24.96%, and 24.97% of the market, respectively [9] - The Asia-Pacific region and Latin America are the largest markets for pesticides, with sales of $25.08 billion and $22.07 billion in 2022, respectively [9] Company Positioning - Taihe Co., Ltd. focuses on the research, production, and sales of pesticide products and functional chemicals, with a strong emphasis on meeting international market demands since its establishment in 2004 [4] - The company has achieved significant revenue from its core products, with fungicides generating ¥1.187 billion (31.07% of total revenue) and herbicides generating ¥1.879 billion (49.18% of total revenue) in 2023 [4] - Taihe Co., Ltd. has established a robust research and development (R&D) system, with 363 patents (73 overseas) and participation in national key research plans [6] Technological Advancements - The company has developed a systematic technological advantage in key synthesis techniques, significantly reducing production costs and enhancing environmental performance [6][7] - Taihe Co., Ltd. has established long-term partnerships with international agricultural giants, ranking 6th in domestic pesticide exports in 2023 [8] - The company has expanded its product offerings in functional chemicals, increasing their share from 4.07% in 2021 to 14.07% in the first half of 2024 [5] Strategic Development - Taihe Co., Ltd. is transitioning from imitation to innovation by establishing a dedicated team for new pesticide creation and investing in the development of new compounds [11][12] - The company has successfully navigated the entire product development process, leading to the successful registration of new products, including the self-created compound that received export registration in July 2024 [13] - The company aims to leverage its technological capabilities and market insights to capture opportunities in high-potential overseas markets [9][10]

核心技术和先进制造双优势发威 核心产品行业地位突出 4月11日，南通泰禾化工股份有限公司(证券简称为"泰禾股份（301665）")正式在深交所创业板上市， 证券代码为"301665"。 作为一家在农药产品领域拥有行业领先地位的集团化制造企业，泰禾股份此次里程碑式的资本市场一 步，既是公司农化产品与功能化学品"双轮驱动"高质量发展的阶段成果，也是公司以国际化视野参与全 球产业链竞合的新起点。 泰禾股份位于江苏省如东县，主要从事农药产品以及功能化学品的研发、生产和销售，现有百菌清、嘧 菌酯、2,4-D等极具市场地位的农化产品，并推出了四氯丙烯等功能化学品。其中，嘧菌酯为全球第一 大杀菌剂，2,4-D为全球最大的苯氧羧酸类除草剂，百菌清为全球第二大的保护性杀菌剂。 公司坚持"上马产品必须要有持续的技术优势"原则，经过二十多年的发展，形成了以氨氧化、氯化、加 氢等反应技术为核心的技术创新体系，拥有363项专利。公司还设有农业部认证的GLP和GEP实验室， 建立了涵盖化合物设计、生物筛选、工艺研发、制剂研究的完整研发体系，先后承担4项国家"十二 五"科技支撑计划、1项"十三五"国家重点研发计划。 公司以高QHSE标准在 ...

今天A股迎来一家新股上市！ 格隆汇新股获悉，泰禾股份（301665.SZ）于4月11日成功登陆深交所创业板，开盘价为45元/股，开盘上涨338.17%； 截至上午收盘涨幅为289.5%，市值180亿元。 公司目前主要从事农药产品以及功能化学品的研发、生产和销售，核心产品包括百菌清、嘧菌酯、2,4-D等，主要客户 为先正达、安道麦、纽发姆、UPL等国际农化公司。 泰禾股份本次发行价格为10.27元/股，对应发行市盈率为13.40倍，低于行业平均市盈率23.01倍，低于同行业可比上市 公司平均市盈率13.41倍；此次发行保荐人是光大证券股份有限公司。 泰禾股份成立于2004年4月，并于2016年6月整体变更为股份公司，总部位于江苏省南通市如东县；公司控股股东为泰 禾集团，实际控制人为田晓宏。 分产品来看，2024年1-6月，来自杀菌剂的收入占主营业务收入的比重为33.40%，除草剂贡献的收入占比为45.56%， 功能化学品的比重为14.07%。 2021年、2022年、2023年及2024年1-6月（报告期），泰禾股份的营业收入分别为35.79亿元、50.99亿元、38.68亿元、 19.59亿元，归母净利润分别 ...

Core Viewpoint - Nantong Taihe Chemical Co., Ltd. (Taihe Co.) has successfully listed on the Shenzhen Stock Exchange's Growth Enterprise Market, with an issue price of 10.27 yuan per share and an opening price of 45.00 yuan per share, highlighting its strong market position and growth potential in the agricultural chemical sector [1] Group 1: Company Overview - Taihe Co. has over 20 years of experience in the agricultural chemical industry, establishing itself as a leader with core products such as Bacillus subtilis, Pyraclostrobin, and 2,4-D, dominating both production scale and technical capabilities [1][2] - The company has developed a complete industrial chain around its three core products, with subsidiaries leading in global production of Bacillus subtilis and 2,4-D, while maintaining a leading position in Pyraclostrobin production in China [2] Group 2: Innovation and Technology - Continuous investment in technology research and development has led to significant achievements, with Taihe Co. holding 363 patents as of June 30, 2024, including 73 overseas invention patents [3] - The company has introduced innovative products such as the new pesticide Cyhalofop-butyl and has established a comprehensive patent protection network, indicating strong future market potential [6] Group 3: Market Position and Strategy - Taihe Co. has been recognized as one of the top 25 companies in the agricultural chemical industry for four consecutive years, reflecting its strong market presence and competitive edge [5] - The company is strategically positioned within the global supply chain, collaborating with international giants like Syngenta and Dow, while focusing on original drug research and formulation sales [5] Group 4: Future Growth and Internationalization - The company aims to expand its business boundaries by transitioning from single product innovation to a product matrix innovation strategy, enhancing its market competitiveness [4][7] - Taihe Co. is committed to internationalization, adapting to global agricultural chemical trends and accelerating its international expansion to ensure sustainable business development [8]